Innoviva, Inc.
INVA· Nasdaq
INVAInnoviva, Inc.
Filed Feb 28, 2023 · 10-K · 59 days after period end · 0000950170-23-005168
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $65.80M | $107.68M | $90.48M | $75.97M |
| Net Income | -$68.31M | $45.65M | $75.02M | $57.86M |
| EPS Diluted | — | — |
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
| — |
| $0.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 28, 2023 · 59 d after period end
